Demetra M. Chatzileontiadou

Clayton, VIC 3800, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced Protection.

COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced Protection.

Journal: Research square

Published: July 03, 2026

Deciphering influenza B virus-derived peptides and their presentation by HLA class I molecules.

Deciphering influenza B virus-derived peptides and their presentation by HLA class I molecules.

Journal: Biochemical Society transactions

Published: January 21, 2026

An HLA Association With COVID-19 Vaccine Reactogenicity Correlates With Fewer SARS-CoV-2 Infections and Monocyte Activation.

An HLA Association With COVID-19 Vaccine Reactogenicity Correlates With Fewer SARS-CoV-2 Infections and Monocyte Activation.

Journal: Research square

Published: January 09, 2026

Method for Determining the Affinity of the T Cell Receptor for the Peptide-Human Leukocyte Antigen Complex.

Method for Determining the Affinity of the T Cell Receptor for the Peptide-Human Leukocyte Antigen Complex.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 01, 2026

Method for Producing Recombinant Soluble T-Cell Receptors.

Method for Producing Recombinant Soluble T-Cell Receptors.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 01, 2026

Method for Performing T Cell Receptor-Peptide-Human Leukocyte Antigen Co-complexation and Structural Analysis.

Method for Performing T Cell Receptor-Peptide-Human Leukocyte Antigen Co-complexation and Structural Analysis.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 01, 2026

Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024.

Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024.

Journal: Journal of virology

Published: April 25, 2025

Molecular basis of potent antiviral HLA-C-restricted CD8+ T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope.

Molecular basis of potent antiviral HLA-C-restricted CD8+ T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope.

Journal: Nature communications

Published: January 08, 2025

Characterisation of an influenza B virus-derived peptide presented by HLA-B*18:01.

Characterisation of an influenza B virus-derived peptide presented by HLA-B*18:01.

Journal: The Biochemical journal

Published: November 11, 2024

Public T cell clonotypes are selected in HLA-B∗57:01+/HIV+ patients independently of the viral load.

Public T cell clonotypes are selected in HLA-B∗57:01+/HIV+ patients independently of the viral load.

Journal: Cell reports

Published: May 02, 2024

The impact of SARS-CoV-2 spike mutation on peptide presentation is HLA allomorph-specific.

The impact of SARS-CoV-2 spike mutation on peptide presentation is HLA allomorph-specific.

Journal: Current research in structural biology

Published: December 21, 2023

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.

Journal: Nature

Published: October 10, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026